TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34971660

Group type: EXPERIMENTAL
Intervention: Anatomic stratification based on T and N category (TNM-8)
Number of subjects: 9468

Group type: EXPERIMENTAL
Intervention: Prognostic stratification with pre-treatment EBV DNA ≥4000 copies/mL
Number of subjects: 9468

Group type: EXPERIMENTAL
Intervention: Anatomic stratification (c-index)
Number of subjects: 9468

Group type: EXPERIMENTAL
Intervention: Prognostic stratification (c-index)
Number of subjects: 9468

Group type: COMPARATOR
Intervention: Existing TNM-8 stage groups (c-index)
Number of subjects: 9468

Group type: COMPARATOR
Intervention: Validation cohort NCT01245959
Number of subjects: 9468

Group type: COMPARATOR
Intervention: Validation cohort NCT01872962
Number of subjects: 9468

Group type: EXPERIMENTAL
Intervention: Post-treatment EBV DNA detectable
Number of subjects: 9468
Study: 32022887

Group type: EXPERIMENTAL
Intervention: Pasireotide, 900 μg, subcutaneously twice a day for 7 days
Number of subjects: 126

Group type: COMPARATOR
Intervention: Hydrocortisone, 100 mg, intravenously 3 times a day for 3 days
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Pasireotide (subgroup analysis)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Hydrocortisone (subgroup analysis)
Number of subjects: 126
Study: 34471156

Group type: EXPERIMENTAL
Intervention: Deep convolutional neural network binary classification model
Number of subjects: 84
Study: 32265834

Group type: EXPERIMENTAL
Intervention: medroxyprogesterone acetate +hMG
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: dydrogesterone +hMG
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: progesterone +hMG
Number of subjects: 450
Study: 33443485

Group type: EXPERIMENTAL
Intervention: Using technology to access health information and services
Number of subjects: 1734

Group type: COMPARATOR
Intervention: Not using technology to access health information and services
Number of subjects: 1734
Study: 32404919

Group type: EXPERIMENTAL
Intervention: 6-minute postural training program (G1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 6-minute rest (G2)
Number of subjects: 40
Study: 32981693

Group type: EXPERIMENTAL
Intervention: Hand-Assisted Retroperitoneoscopic Donor Nephrectomy (HARP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Open Anterior Approach Donor Nephrectomy (AA)
Number of subjects: 100
Study: 33239943

Group type: EXPERIMENTAL
Intervention: Yoga stretching
Number of subjects: 10
Study: 34417681

Group type: EXPERIMENTAL
Intervention: Spirituality-based program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 34282693

Group type: EXPERIMENTAL
Intervention: Bacteraemia confirmed by blood culture
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Bacteraemia
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Antibiotic administration during resuscitation
Number of subjects: 200
Study: 32525465

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Nonadherence
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Alcohol use
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Viral load <200 copies/mL
Number of subjects: 940
Study: 35008040

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (AS) with 1000 IU·d‐1 natural vitamin E and 1000 mg·d‐1 vitamin C
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 32799362

Group type: EXPERIMENTAL
Intervention: Hydrolyzed marine collagen (Vinh Wellness Collagen, VWC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35660812

Group type: EXPERIMENTAL
Intervention: RVD plus ASCT
Number of subjects: 722

Group type: COMPARATOR
Intervention: RVD alone
Number of subjects: 722
Study: 32511981

Group type: EXPERIMENTAL
Intervention: Ripretinib 150 mg once daily
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo once daily
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Ripretinib
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 36261200

Group type: EXPERIMENTAL
Intervention: Thoracolumbar interfacial plane block (TLIP)
Number of subjects: 64
Study: 34085467

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Combination group (EA + acupoint catgut embedding)
Number of subjects: 138
Study: 32512513

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS
Number of subjects: 118

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 118
Study: 35057686

Group type: EXPERIMENTAL
Intervention: Gain-framed messages
Number of subjects: 981

Group type: EXPERIMENTAL
Intervention: Loss-framed messages
Number of subjects: 981

Group type: COMPARATOR
Intervention: Control group (non-framed group)
Number of subjects: 981
Study: 34419090

Group type: EXPERIMENTAL
Intervention: Oropharyngeal administration of colostrum (0.4 ml every 3 hours for 10 days within the first 48 hours after birth)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Oropharyngeal administration of colostrum
Number of subjects: 252
Study: 32696887

Group type: EXPERIMENTAL
Intervention: Anxiety disorder severity
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Higher anxiety severity
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Higher number of anxiety diagnoses
Number of subjects: 54
Study: 34259920

Group type: EXPERIMENTAL
Intervention: Azithromycin suspension administered twice daily by gargling for 30 seconds and swallowing, starting on the first day of chemotherapy.
Number of subjects: 70

Group type: COMPARATOR
Intervention: No azithromycin (control group).
Number of subjects: 70
Study: 32266415

Group type: EXPERIMENTAL
Intervention: Over-the-top anterior cruciate ligament reconstruction technique that preserves the hamstring attachment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Classical reconstruction technique
Number of subjects: 20
Study: 34265266

Group type: EXPERIMENTAL
Intervention: View of Relocation Scale (VRS)
Number of subjects: 202
Study: 35225819

Group type: EXPERIMENTAL
Intervention: TeleClinical Care (TCC) with usual care
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control (usual care only)
Number of subjects: 164
Study: 34711335

Group type: EXPERIMENTAL
Intervention: Paclitaxel drug-coated devices (DCDs)
Number of subjects: 4316

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 4316

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4316
Study: 35585281

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (FiO2: 15%)
Number of subjects: 29
Study: 33189641

Group type: EXPERIMENTAL
Intervention: Watchman FLX device
Number of subjects: 165
Study: 34862643

Group type: EXPERIMENTAL
Intervention: Low-Intensity Focused Ultrasound (LIFU) treatment, power output 2.5 W/cm2, frequency 1 MHz, treating time 20 minutes
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low-Intensity Focused Ultrasound (LIFU) treatment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham group (LIFU without energy output)
Number of subjects: 16
Study: 33103776

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation exercise (PMRE)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 145
Study: 33305973

Group type: EXPERIMENTAL
Intervention: Nipple shield use (Pain Group)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Nipple shield use (Control Group)
Number of subjects: 59
Study: 32329778

Group type: EXPERIMENTAL
Intervention: SPEEDI_Late
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: SPEEDI_Early
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 90
Study: 35661214

Group type: EXPERIMENTAL
Intervention: Fasting-mimicking diet (FMD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mediterranean diet
Number of subjects: 40
Study: 32394278

Group type: COMPARATOR
Intervention: SLCTlow (100 kVp)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: DLCTlow (120 kVp)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: DLCThigh (120 kVp)
Number of subjects: 25
Study: 33632649

Group type: EXPERIMENTAL
Intervention: Provider mobile phone application plus patient educational tool
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group for provider mobile phone application plus patient educational tool
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Provider mobile phone application only
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group for provider mobile phone application only
Number of subjects: 14
Study: 34322745

Group type: EXPERIMENTAL
Intervention: Prognostic nomogram for predicting overall survival (OS)
Number of subjects: 5585

Group type: EXPERIMENTAL
Intervention: Nomogram calibration plots
Number of subjects: 5585
Study: 34796837

Group type: EXPERIMENTAL
Intervention: Methotrexate combined with prednisolone
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Methotrexate combined with anti-TNF (certolizumab-pegol)
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Methotrexate combined with CTLA-4Ig (abatacept)
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Methotrexate combined with anti-IL6 receptor (tocilizumab)
Number of subjects: 347

Group type: COMPARATOR
Intervention: Baseline plasma chemokine levels
Number of subjects: 347
Study: 34444805

Group type: EXPERIMENTAL
Intervention: FIT Game intervention (n = 881)
Number of subjects: 1859

Group type: COMPARATOR
Intervention: Control condition (n = 978)
Number of subjects: 1859
Study: 33068146

Group type: EXPERIMENTAL
Intervention: Allogeneic human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) combined with high tibial osteotomy (HTO)
Number of subjects: 93
Study: 35549460

Group type: EXPERIMENTAL
Intervention: Robotic-Assisted Fluoroscopic-Guided (RAF)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Ultrasound-Guided (US)
Number of subjects: 71
Study: 33076805

Group type: EXPERIMENTAL
Intervention: CSP group (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 60
Study: 32053133

Group type: EXPERIMENTAL
Intervention: 3 months of FOLFOX or CAPOX chemotherapy
Number of subjects: 1254

Group type: COMPARATOR
Intervention: 6 months of FOLFOX or CAPOX chemotherapy
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: FOLFOX chemotherapy (3 months)
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: CAPOX chemotherapy (3 months)
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: 3 months of chemotherapy
Number of subjects: 1254
Study: 35762428

Group type: EXPERIMENTAL
Intervention: Kindergarten mode treatment (test group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (treated alternately with adult patients)
Number of subjects: 30
Study: 34581765

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (20 μg/d)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: High-protein (HP) yogurt (10 g protein/100 g)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Normal-protein (NP) yogurt (3.5 g protein/100 g)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo (no vitamin D)
Number of subjects: 200
Study: 35484327

Group type: EXPERIMENTAL
Intervention: Mandibular advancement appliance (MAA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Without MAA
Number of subjects: 16
Study: 34990497

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BoNT‐A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Oral appliance (OA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline solution (SS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Comparison between BoNT‐A and OA
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison between BoNT‐A/OA and SS
Number of subjects: 100
Study: 32728058

Group type: EXPERIMENTAL
Intervention: Lower eGFR
Number of subjects: 0
Study: 34921497

Group type: EXPERIMENTAL
Intervention: Cold exposure (cooling vest perfused at 14°C for 2 hours)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No cold exposure (control)
Number of subjects: 10
Study: 32816787

Group type: EXPERIMENTAL
Intervention: Physiotherapist-led exercise
Number of subjects: 256

Group type: COMPARATOR
Intervention: Ultrasound-guided corticosteroid injection
Number of subjects: 256

Group type: COMPARATOR
Intervention: Exercise leaflet
Number of subjects: 256

Group type: COMPARATOR
Intervention: Unguided corticosteroid injection
Number of subjects: 256
Study: 33356966

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 60
Study: 35725264

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 900

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 900
Study: 32687296

Group type: EXPERIMENTAL
Intervention: Electroneurostimulation (ENS) of the cervical sympathetic ganglia combined with gymnastics of the oculomotor muscles and shoulder girdle (MG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Muscle gymnastics (GoC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo ENS (CG)
Number of subjects: 120
Study: 35854327

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) taken daily until birth
Number of subjects: 158

Group type: COMPARATOR
Intervention: Metformin taken daily until birth
Number of subjects: 158
Study: 34106218

Group type: EXPERIMENTAL
Intervention: Granuloma annulare (GA)
Number of subjects: 5137
Study: 32552707

Group type: EXPERIMENTAL
Intervention: Adjustment of IOL power for the second eye as 50% of the RE of the first eye
Number of subjects: 94

Group type: COMPARATOR
Intervention: No modification of IOL power (Control group)
Number of subjects: 94
Study: 33563569

Group type: EXPERIMENTAL
Intervention: Continuous positive air pressure with a steady pressure of 4 cm H2O
Number of subjects: 80

Group type: COMPARATOR
Intervention: Continuous positive air pressure with ideal therapeutic pressure
Number of subjects: 80
Study: 32483622

Group type: EXPERIMENTAL
Intervention: Medium-dose D1 activation (combination of levodopa and a D2 antagonist)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Low-dose D1 activation
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: High-dose D1 activation
Number of subjects: 4
Study: 34643642

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil
Number of subjects: 2258

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2258
Study: 33663383

Group type: EXPERIMENTAL
Intervention: Educational lecture on JNET classification for NEE group
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Educational lecture on JNET classification for LEE group
Number of subjects: 17

Group type: COMPARATOR
Intervention: HEE group (control)
Number of subjects: 17
Study: 35192440

Group type: EXPERIMENTAL
Intervention: Client-centered occupational therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: General occupational therapy
Number of subjects: 20
Study: 33591929

Group type: EXPERIMENTAL
Intervention: Mindfulness training for military veterans
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various psychological interventions (procedural, sensory, behavioral, cognitive, relaxation, hypnosis, mindfulness, emotional, patient-generated narratives)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychological interventions alongside analgesics or anesthetics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychological interventions for patients undergoing abdominal and general surgery
Number of subjects: 0
Study: 32791393

Group type: EXPERIMENTAL
Intervention: Dermal staples
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intradermal sutures
Number of subjects: 40
Study: 34764377

Group type: EXPERIMENTAL
Intervention: Pinch and blow method
Number of subjects: 50

Group type: COMPARATOR
Intervention: No pinch method
Number of subjects: 50
Study: 33248590

Group type: EXPERIMENTAL
Intervention: Chitosan oligosaccharides (COS) supplementation at 200 mg/kg
Number of subjects: 108

Group type: COMPARATOR
Intervention: Basal diet under cycle heat stress (HS group)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Basal diet and raised under normal temperature (CON group)
Number of subjects: 108
Study: 35510598

Group type: EXPERIMENTAL
Intervention: In-person instructions
Number of subjects: 100

Group type: COMPARATOR
Intervention: Video instructions
Number of subjects: 100
Study: 34911199

Group type: EXPERIMENTAL
Intervention: Deep learning enhanced images
Number of subjects: 0

Group type: COMPARATOR
Intervention: Degraded images
Number of subjects: 0
Study: 33570841

Group type: EXPERIMENTAL
Intervention: QuizTime smartphone application learning platform
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional avenues of knowledge dissemination
Number of subjects: 0
Study: 33082712

Group type: EXPERIMENTAL
Intervention: Bergamot essential oil
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sweet orange essential oil
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bergamot juice
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sweet orange juice
Number of subjects: 80

Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 80

Group type: COMPARATOR
Intervention: Positive drugs
Number of subjects: 80
Study: 35313268

Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 1.5 ml ropivacaine
Number of subjects: 118
Study: 32955138

Group type: EXPERIMENTAL
Intervention: Abemaciclib
Number of subjects: 0
Study: 32852361

Group type: EXPERIMENTAL
Intervention: Continue CTX prophylaxis
Number of subjects: 72

Group type: COMPARATOR
Intervention: Stop CTX prophylaxis
Number of subjects: 72
Study: 33443859

Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control (tablets devoid of any scent)
Number of subjects: 144
Study: 35989130

Group type: EXPERIMENTAL
Intervention: Error-focused video feedback
Number of subjects: 37

Group type: COMPARATOR
Intervention: Correct-focused video feedback
Number of subjects: 37
Study: 34337074

Group type: EXPERIMENTAL
Intervention: Antibiotic-loaded bone cement repair
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional vacuum sealing draining treatment
Number of subjects: 36
Study: 33189747

Group type: EXPERIMENTAL
Intervention: Hypothermia
Number of subjects: 168

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: MRI injury score
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: MRI patterns
Number of subjects: 168
Study: 32795506

Group type: EXPERIMENTAL
Intervention: PICTURE (Predicting Intensive Care Transfers and other UnfoReseen Events)
Number of subjects: 133089

Group type: COMPARATOR
Intervention: Regularized logistic regression
Number of subjects: 133089
Study: 35168586

Group type: EXPERIMENTAL
Intervention: Education program with peer support on social media (Facebook Page of Antibiotic Use), 2 weekly sessions of 90 minutes each.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Education program with peer support on social media (Facebook Page of Antibiotic Use).
Number of subjects: 48
Study: 34106941

Group type: EXPERIMENTAL
Intervention: WW52 (52-week behavioural weight management intervention)
Number of subjects: 594

Group type: COMPARATOR
Intervention: WW12 (12-week behavioural weight management intervention)
Number of subjects: 594

Group type: COMPARATOR
Intervention: BI (brief self‐help intervention)
Number of subjects: 594
Study: 33595905

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 10142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10142
Study: 32916181

Group type: EXPERIMENTAL
Intervention: Motor Exercise (ME)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Cardiovascular Exercise (CE)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 71
Study: 35770578

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at 2-Hz near the left cervical ganglia
Number of subjects: 24
Study: 33503114

Group type: EXPERIMENTAL
Intervention: ProCore 20G FNB needle
Number of subjects: 20

Group type: COMPARATOR
Intervention: 22G FNA needle
Number of subjects: 20
Study: 32825517

Group type: EXPERIMENTAL
Intervention: NOURISH intervention for mothers (2 × 12 week modules starting at 4 and 14 months)
Number of subjects: 70
Study: 35841016

Group type: EXPERIMENTAL
Intervention: 3% hydrogen peroxide solution
Number of subjects: 16

Group type: COMPARATOR
Intervention: Water-moistened toothbrush
Number of subjects: 16

Group type: COMPARATOR
Intervention: Comparison between intervention and control groups
Number of subjects: 16
Study: 34488794

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention combining family-based PA counselling and after-school exercise clubs
Number of subjects: 506

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Sensitivity analyses
Number of subjects: 506
Study: 32222042

Group type: EXPERIMENTAL
Intervention: TRAIN (unilateral maximal voluntary contractions of the wrist extensors)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: TRAIN + STIM (MVCs of wrist extensors with simultaneous SR stimulation)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: TRAIN + STIM
Number of subjects: 27
Study: 32796413

Group type: EXPERIMENTAL
Intervention: Phototherapy (630 nm, 4.6 J/cm2, 6 J per point, 16 points, LED session)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Phototherapy (LED session)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (PLA session)
Number of subjects: 16
Study: 32109005

Group type: EXPERIMENTAL
Intervention: New amino acid-based infant formula (Blemil Plus Elemental)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control formula (Neocate)
Number of subjects: 30
Study: 36368248

Group type: EXPERIMENTAL
Intervention: Wormwood vaginal gel
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 32640318

Group type: EXPERIMENTAL
Intervention: Prophylactic cerebrospinal fluid drainage (CSFD) used in 78 patients (73.6%)
Number of subjects: 106

Group type: COMPARATOR
Intervention: No cerebrospinal fluid drainage (CSFD) used in 28 patients (26.4%)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid drainage (CSFD) complications
Number of subjects: 106